科利吉姆制药 COLL
$24.21 −$0.95 (-3.78%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $24.29 +0.33%
开盘$24.06
昨收$25.16
当日区间$23.71 – $24.80
成交量775.6K
市值$752.34M
市盈率（TTM）22.2
股息率–
COLL 相关新闻
匹配 Collegium Pharmaceutical 或代码 COLL 的头条新闻，按最新排序。
- Truist Financial Initiates Collegium Pharmaceutical(COLL.US) With Buy Rating, Announces Target Price $49
- Leerink Partners Initiates Collegium Pharmaceutical(COLL.US) With Buy Rating, Announces Target Price $45
- H.C. Wainwright Reaffirms Their Buy Rating on Collegium Pharmaceutical (COLL)
- H.C. Wainwright Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Maintains Target Price $60
- Piper Sandler Maintains Collegium Pharmaceutical(COLL.US) With Hold Rating, Cuts Target Price to $43 负面
- Needham Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Cuts Target Price to $46 负面
- Barclays Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Cuts Target Price to $48 负面
- Barclays Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Maintains Target Price $56
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Collegium Pharmaceutical (COLL), Myriad Genetics (MYGN) and Mineralys Therapeutics, Inc. (MLYS)
- Truist Financial Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating
- Needham Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Maintains Target Price $56
- Analysts Are Bullish on These Healthcare Stocks: Collegium Pharmaceutical (COLL), Sionna Therapeutics, Inc. (SION) 正面
- H.C. Wainwright Sticks to Its Buy Rating for Collegium Pharmaceutical (COLL)
- Piper Sandler Maintains Collegium Pharmaceutical(COLL.US) With Hold Rating, Maintains Target Price $44
- A Quick Look at Today's Ratings for Collegium Pharmaceutical(COLL.US), With a Forecast Between $44 to $60
暂无评论——快来第一个聊聊 COLL。
登录后参与讨论。